BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Anna Wróblewska, Agnieszka Bernat, Anna Woziwodzka, Joanna Markiewicz, Tomasz Romanowski, Krzysztof P. Bielawski, Tomasz Smiatacz, Katarzyna Sikorska. Interferon lambda polymorphisms associate with body iron indices and hepatic expression of interferon-responsive long non-coding RNA in chronic hepatitis CClinical and Experimental Medicine 2017; 17(2): 225 doi: 10.1007/s10238-016-0423-4
2
Quan Liang. Role of transferrin receptor in hepatitis C viral infectionInfection International 2018; 7(2): 33 doi: 10.2478/ii-2018-0016
3
N. G. Danilenko, M. G. Siniauskaya, S. P. Lukashyk, I. A. Karpov, O. G. Davydenko. “Double Punch”: Hepatitis C in Patients with Genetic Defects of Iron MetabolismCytology and Genetics 2019; 53(5): 407 doi: 10.3103/S0095452719050062
4
James C. Barton, J. Clayborn Barton, Paul C. Adams. Prevalence and characteristics of anti-HCV positivity and chronic hepatitis C virus infection in HFE p.C282Y homozygotesAnnals of Hepatology 2019; 18(2): 354 doi: 10.1016/j.aohep.2018.11.005
5
Dong-Mei Zou, Wan-Ling Sun. Relationship between Hepatitis C Virus Infection and Iron OverloadChinese Medical Journal 2017; 130(7): 866 doi: 10.4103/0366-6999.202737
6
Shintaro Nanba, Fusao Ikeda, Nobuyuki Baba, Koichi Takaguchi, Tomonori Senoh, Takuya Nagano, Hiroyuki Seki, Yasuto Takeuchi, Yuki Moritou, Tetsuya Yasunaka, Hideki Ohnishi, Yasuhiro Miyake, Akinobu Takaki, Kazuhiro Nouso, Yoshiaki Iwasaki, Kazuhide Yamamoto. Association of hepatic oxidative stress and iron dysregulation with HCC development after interferon therapy in chronic hepatitis CJournal of Clinical Pathology 2016; 69(3): 226 doi: 10.1136/jclinpath-2015-203215
7
Katarzyna Sikorska, Agnieszka Bernat, Anna Wróblewska. Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosisHepatobiliary & Pancreatic Diseases International 2016; 15(5): 461 doi: 10.1016/S1499-3872(16)60135-2
8
Zhijiang Miao, Zhenrong Xie, Jing Miao, Jieyu Ran, Yue Feng, Xueshan Xia. Regulated Entry of Hepatitis C Virus into HepatocytesViruses 2017; 9(5): 100 doi: 10.3390/v9050100
9
Driton Vela. Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical markerMolecular Medicine 2018; 24(1) doi: 10.1186/s10020-018-0008-7